RxDoctor Payments DataLook up a doctor →

Jose Foradada, MD

Neurology with Special Qualifications in Child Neurology · Tampa, FLNPI 1841308475

Payments from drug & device makers

$13,404in general payments, 2019–2025

Across 771 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tris Pharma Inc$3K
  • UCB, Inc.$2K
  • Jazz Pharmaceuticals Inc.$1K
  • Supernus Pharmaceuticals, Inc.$910
  • Eisai Inc.$734
  • Corium, LLC$694
  • plus $5K from 37 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Tris Pharma Inc231$2,792
UCB, Inc.80$2,177
Jazz Pharmaceuticals Inc.49$1,087
Supernus Pharmaceuticals, Inc.63$910
Eisai Inc.33$734
Corium, LLC46$694
Noven Therapeutics, LLC21$474
Sunovion Pharmaceuticals Inc.29$446
Ironshore Pharmaceuticals Inc.23$438
Neos Therapeutics, LP24$353
Neurelis, Inc.17$305
Aquestive Therapeutics, Inc.16$300
Sumitomo Pharma America, Inc.22$289
Catalyst Pharmaceuticals, Inc.8$211
Greenwich Biosciences, Inc.10$205
Collegium Pharmaceutical, Inc.10$194
Adlon Therapeutics L.p.10$182
Cranial Technologies, Inc5$158
Takeda Pharmaceuticals U.S.A., Inc.8$152
Neurocrine Biosciences, Inc.4$137
Biohaven Pharmaceuticals, Inc.8$136
Acadia Pharmaceuticals Inc5$126
Biogen6$114
Vertical Pharmaceuticals, LLC6$100
Upsher-smith Laboratories LLC4$68
Biohaven Pharmaceutical Holding Company Ltd.3$59
Amneal Pharmaceuticals LLC3$58
PTC Therapeutics, Inc.2$57
Immedica Pharma US, Inc.2$52
Biomarin Pharmaceutical Inc.4$50
Genentech USA, Inc.2$50
Rhodes Pharmaceuticals L.p.3$49
Piramal Critical Care3$47
Arbor Pharmaceuticals, Inc.2$29
Zogenix Inc.1$24
Hyperfine Operations, Inc.1$23
Noven Pharmaceuticals, Inc.1$21
Mallinckrodt Enterprises LLC1$20
Saol Therapeutics Inc.1$18
Medtronic1$18
AstraZeneca1$18
Livanova USA, Inc.1$15
Lilly USA, LLC1$14

How this compares

$13,404 in reported general payments places this provider in the 65th percentile of 137 neurology with special qualifications in child neurology providers in Florida.

See all neurology with special qualifications in child neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$76,010
Medicare patients
32
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology with special qualifications in child neurology in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →